NBY News and Press, NovaBay Pharmaceuticals Inc. From 08/08/19

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2019 Results Conference Call August 8, 2019 4:30 PM ET Company Participants Jason Raleigh – Chief Financial Officer Jody Cain – Investor Relations-LHA Justin Hall – President and Chief Executive Officer Conference Cal...

NovaBay (NYSEMKT: NBY ): Q2 GAAP EPS of -$0.14 misses by $0.01 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Avenova ® sales increase 9% and operating expenses decline 47% over the 2019 first quarter Conference call to be held Thursday August 8, 2019 at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on co...

McDermott International (NYSE: MDR )  -36%  on Q2 earnings . More news on: McDermott International, Inc., TDH Holdings, Inc., SS&C Technologies Holdings, Inc., Stocks on the move, Read more ...

Nano cap NovaBay Pharmaceuticals ( NBY +37.3% ) is up on almost a 4x surge in volume after reporting Q2 results this morning. Sales were $1.8M, down over  35%  from a year ago. Aenova sales were up  9%  sequentially to $1.6M. More news on: NovaBay Pharmaceuticals, I...

Gainers:  NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...

Medley Management (NYSE: MDLY ) +35%  as Sierra, Medley Capital, Medley Management amend merger deals . More news on: Medley Management Inc., Sintx Technologies, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...

NovaBay (NYSEMKT: NBY ): Q2 revenue of $1.8M (-39.0% Y/Y) beats by $0.27M . The company will report its 2Q19 results on 8th August, 2019. Press Release More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,

Company to hold second quarter 2019 conference call on August 8 NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, reports net sales of $1.8 million for the three months...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that President and CEO Justin Hall has issued the following letter to stockholders: To My Fellow Stockholders: ...